Css LLC Horizon Therapeutics Public LTD CO Transaction History

Css LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$98.98 - $115.74 $2.31 Million - $2.7 Million	23,300 Added 259.58%	32,276 $3.73 Million
Q2 2023 Aug 14, 2023	BUY	$96.34 - $112.38 $529,870 - $618,090	5,500 Added 158.23%	8,976 $923,000
Q1 2023 May 15, 2023	SELL	$107.32 - $113.5 $2,575 - $2,724	-24 Reduced 0.69%	3,476 $379,000
Q4 2022 Feb 14, 2023	BUY	$62.39 - $113.8 $218,365 - $398,300	3,500 New	3,500 $398,000
Q1 2021 May 17, 2021	SELL	$71.83 - $95.48 $264,765 - $351,939	-3,686 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$67.0 - $84.39 $6.94 Million - $8.74 Million	-103,576 Reduced 96.56%	3,686 $269,000
Q3 2020 Nov 16, 2020	BUY	$55.23 - $79.93 $82,845 - $119,895	1,500 Added 1.42%	107,262 $8.33 Million
Q2 2020 Aug 14, 2020	BUY	$30.2 - $56.98 $3.19 Million - $6.03 Million	105,762 New	105,762 $5.88 Million

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

Stay updated on Css LLC with notifications on news.